PFE

Anxious_Cheetah5589

Probably true in mega cap tech. Stodgy dividend payers have done very well lately (PFE, CAT, JNJ, WMT, MRK, VZ, etc). It feels like a collapse if you're overweight tech, but it's really just a healthy rotation.

Portfoliana

Instead of chasing "hot" sectors, I'd flip the question: which sectors are currently *out of favor* but have strong fundamentals? Healthcare and pharma got hammered by regulatory uncertainty and tariff fears - companies like UNH or PFE are trading at significant discounts to their 5-year averages. Same with enterprise software after the AI-will-replace-everything panic - many established SaaS names with sticky revenue are down 30-40% despite solid cash flows. The value investor's edge isn't predicting which theme wins, it's buying quality when everyone else is running away. Your S&P 500 base is smart, but if you want sector exposure, consider looking at what's unloved rather than what's in the headlines. The best time to buy defense stocks was before the Ukraine war, not after they tripled.

trsx5

About to full port $PFE, thats kinda where im at at this moment.

Dothemath2

PFE

jnas_19

PFE and ENPH was a good mind fuck lol

Ithinktoodeep55

alright guys. its official I've had the worst hit rate in my investing career the past month (negative) - bought adbe, bought crm, bought msft (negative) - bought paypal before earnings (mostly as a whipsaw quick return since it was at 50) (negative) - did not sell/trim NVO prior to earnings - (negative) - did not sell/trim any AMD prior to earnings (negative) - trimmed 30% of PFE prior to earnings (negative) - Trimmed 20% of GOOGLE prior to earnings (negative) - accumulated SOFI since 26/share (negative) - Sold Enphase Prior to earnings (Positive) - Accumulated ELF prior to earnings **That's a 1/11 hit rate.** I guess that's what I get for buying tons of AMD at 88 share last year, google at 150/share, and SOFI at 8-9 share last year a lot of these were accumulations at good levels so im hoping they turn around eventually.

No-Improvement3164

Dividend stock. That OI wasn’t there a week ago. PFE at 10 year low. AI painted pictures as bright as possible. What’s there to look forward too? Now battle of companies. I bought 20 strikes and sold 27 strikes. PFE above 26-27 the way I see it it’s 45% gains. Let them get called away.

No-Improvement3164

Look at the OI on PFE 1/2028 calls.

Ithinktoodeep55

the past few weeks has been absolutely every decision being the wrong decision in the short term, I'm actually impresssed. kept/bought adbe/crm/sofi/msft/nvo/amd/crm - ALL crashed sold PFE after earnings due to soft guidance - its up now more sold ENPH - its up 25%

zbern

LLY is a breath of fresh air for my LNTH holding. NVO, PFE, and MRK are all either suffering from competition, soon to be expired patents, and scrambling to disassociate with China/India manufacturing. Also u/_hiddenscout turned me on to this article and it blew my mind. https://fortune.com/2025/06/17/novo-nordisk-ozempic-wegovy-semaglutide-canada-patent-protection-fee/](https://fortune.com/2025/06/17/novo-nordisk-ozempic-wegovy-semaglutide-canada-patent-protection-fee/

PeddyCash

Well my PFE calls didn’t work out. Thankfully they are June expiration

Happy-Champion1661

MRK puts and it pumps PFE NVO LLY red LMAO at least my PFE strangle printed

Samjabr

Imagine having a retirement account with PARA, INTC, PFE Just watching your life churn away for years

Ithinktoodeep55

thoughts on PFE? been holding this company for 1.5 years at a mild loss (5%) for basically the lower valuation and 6.5% dividend. Company beat earnings again but has tempered FY26 guidance for EPS and revenue, accounting for an agreement with donald trump that could compress margins. I'm wondering if the new fed chair being appointed this year that there will be more of an appetite for higher dividend stocks and PFE may benefit? (lower interest rates)

No-Improvement3164

Once again PFE dividend goes up and stock goes down

stickman07738

I always viewed PFE as an acquirer and not innovative - some acquisition went well but most were poorly done. I was really liking the Seagen acquisition but I now have my doubts and still watching from the side-lines. MRK is another story and too tough for me to call - for me, this is the break year for the CEO.

zbern

MRK and PFE didn’t have bad earnings from a numbers standpoint, but the guidance from both did not bode well for the US healthcare in the mid-term length. Looks like a lot of patents are coming up on expiration and companies are buying up smaller biotech/pharma companies because of it. Also, both are mentioning uncertainties with the current administration’s take on healthcare in general. And, it seems the ‘American First’ onshoring efforts in general are playing a big factor right now with trying to become less reliant on China/India manufacturing.

Happy-Champion1661

MRK puts, PFE straddle, PEP puts at open thinking about UBER calls, anyone?

WSB-Rizzler

!banbet PFE 27.5 1w

xfolder254

for tomorrow my guesses are 🍏 $PLTR $PYPL $NXPI $IT 🍎 $PEP $PFE $MRK $TER $RMBS

fordprecept

I'm definitely seeing a lot of stocks ready to fly soon. PFE, NVO, MELI, UBER, SMR, AES, FISV, CRWV, NBIS On a riskier play note, I think NIO and EVTL could be multi-baggers this year. Easily up at least 80% from current levels, imo.

Groucho-and-Harpo

If you buy a LEAP and then sell a call, that’s really more of a diagonal or PMCC and you actually run the risk of not just getting called away but also losing on the trade if the underlying shoots up faster than you expect. It seems that you are chasing growth and premiums at the same time. Essentially you are fighting yourself with your trades. My favorite for doing covered calls is PFE. But I also do bullish put spreads. Covered calls are initiated where I see PFE hitting resistance and bullish put spreads are initiated where I see strong support. I don’t even look at RSI…simple resistance and support trendiness and evidence of the underlying bouncing off of them serve as my guideline for when to initiate a trade. I think the best way to do covered calls is as follows: 1) Pick an underlying which has a clear trading pattern and valuation to support the trading pattern. Stocks with consistent dividends have the added advantage of this additional source or income and stability. 2) Sell calls ATM or slightly OTM when resistance is clear and unlikely to be breached. 3) Don’t panic if the stock shoots up. Hold until it reverses. If it doesn’t reverse for several weeks, let it get called away and start over. 4) Do bullish put spreads when the underlying is near a support level.

ThatOneRedditBro

Bear market vibes Feels like we're due for a leg down until mid-terms, IMO. With all the political tension and lack of rate cuts, with mid-terms, the big boys aren't going to come in with volume. You have rare earth metal prices going up that's driving hits to profit margins, inflation elevated, layoffs, no rate cuts, potential WWIII, midterms...> If you're a serious investor you're going to be playing it very safe with some beaten down DOW names imo. I know those defensive stocks aren't the most sexy, but those high dividend plays could be the rotation coming. Look t PFE. It's divy is huge and it's slowly inching it's way up. LMT...OXY.....

bigfern91

Bought PFE recently

Difficult_Fig_1582

I always go out 1 mth. Right now I can sell strike at $27. For .15 At PFE

jamustigran

Putt PFE !

jamustigran

Putt PFE

xflashbackxbrd

More demand after all this is over though right. Folks who bought PFE during trump 1 before covid made out pretty well.

txholdup

I am going back to Alaska again this summer and I don't have to sell META to do it. META sits in a taxable account with 9 other positions. If I needed to raise capital I would sell PFE with a 9% gain or IBM with a 19% gain. META closed at 3413% gain, why sell it when I have more tax efficient options. And besides, knowing that when a friend or a 501(3)c gets my META, the capital gain goes away, makes me smile.

drew-gen-x

If you would ignore the Covid time period, the $PFE charts look pretty good. I treat those boomer divy stocks as bonds and just take the dividend payouts as cash to reinvest somewhere else.

SolubleAcrobat

PFE bagholder here. Finally green after two years.

PeddyCash

Shorting PFE here. May puts

ArtisticAside8224

What stocks are you wheeling to produce over 120 percent annual returns ? I wheel boring dividend stocks and I make about 2% a month. I'm wheeling Ko, PG, Xom, NEE, PFE etc.

lysergalien

One of them seed oil head ahh dudes. Its giving puts on PFE

Punchmeinmyface25

PFE cure cancer and fat. It popping. Catch it catch it catch it

Punchmeinmyface25

PFE is springing

No-Improvement3164

That’s HUUUGE for PFE. 🫲🏻🫱🏻

No-Improvement3164

PFE shrecking

brucekeller

but PFE also means Poopy Farts Extreme

Punchmeinmyface25

PFE cure cancer and fat. Run it down. It’s a coiled spring.

I-STATE-FACTS

PFE - Zoloft LLY - Prozac GSK - Paxil ABBV - Range of generic drugs in the same space

RevolutionaryPhoto24

I bought my first ever ETF today. Well, sort of. Wrote puts on VT (and PFE & BRKB.) What is happening?!?

Justanunknownauthor

You dumped NVDA for PFE?

ETFBro4DaWinz

Probably will just keep accumulating PFE if there's an aggressive sell-off again.

wolvendael

So this is gaslighting 101 by a VKTX baggie. No stock has a bigger cult following than VKTX. How many times have you heard of ALT? My guess is few and far between - hence it doesn’t pass the smell test that it has a cult following. ALT does have a few followers who objectively look at very good science and differentiating factors that continue to be ignored by WS and bashed by competitors. The truth about pemvidutide: it’s a 1:1 glucagon to GLP agonist, which skews it less towards max weight loss (-15% in its straight obesity trial) and better suited for MASH. It had its phase 2 results (which weee excellent) published in The Lancet, has late-breaker podium presentation at the largest hepatology conference in Nov, receive BTD from the FDA for phase 3, has a new commercially-focused CEO, and is now likely in talks with a partner. Yet it barely sits above cash value. That is what ALT investors are focused on - the mispricing or deliberate suppression of the share price. The competitive landscape favors pemvidutide: it has the classic MASH and fibrosis response of other drugs in its class, but it has BIC tolerability. This is what matters most in MASH: staying on the drug. Hepatologists and GIs have repeatedly said that they are not chasing weight loss. It’s nice to have, but GLP1s that have 10-20% diacontinuations (like survodutide) are not going to be prescribed. Patients have a serious liver disease and have to remain on the drug. Pemvi has <1% tolerability, mainly due to its EuPort construction, which slows absorption and decrease max concentration. This is a large differentiating factor for pemvi. After that, its results with prescriber-preferred noninvasive tests (VCTE, ELF, PDFF) were so good and statistically significant that the global head of MASH for Lilly called them “beautiful” at AASLD conference in Nov. and now FDA is moving away from biopsy and allowing NITs for pivotal trials - right at the perfect time for ALT’s p3 design. ALT bulls aren’t trying to convening you that pemvidutide will be the number 1 drug of all time, or that it will replace all other MASH drugs. It’s simply that pemvidutide does seem poised to capture a lot of the market, has been derisked due to FDA BTD (conferring a historical 80% prob of success from a Jefferies analysis), and that every other drug entering p3 in MASH with good data and BTD has been bought for $3bn to $5bn. It’s a hot field. There are many legacy players with no presence - including GSK, AZ, PFE, and many others looking to get into the MASH field. ALT longs would simply like to see the company rerate to fair value. It’s certainly long overdue.

2Hosslovescash

NVO borrowed PFE’s best pill.

Negative_Win_5117

Yeah. I trade spreads all the time but legging into your own spread on something as boring as PFE and making 100% is wild.

No-Improvement3164

Whys there so much volume on the January 2028 ITM calls on PFE today?

dvdmovie1

In 2023 people kept advocating for PYPL on here saying "it's cheaper than NVDA" and then people kept trying to buy the PYPL dip on here in 2024, then in 2025 and now again in 2026... at some point it starts to feel like people don't want to actually look for new ideas and just keep copying others/going back to the same set of things when they don't want to buy growth. See also: frequently mentioned PFE, which has been a "buy the dip" mention on here for years too, like in 2023 when I was frequently told that it was a better buy than LLY because "PFE is cheap and they have an obesity drug too." The obesity drug was a failure, PFE has an atrocious record over the last couple of decades and yet, because it's a household name, it has a high dividend yield and a low p/e that somehow allowed people on here to overlook the incredibly lackluster track record the company has had over the last 20 years or so. Hopefully for all the bagholders it gets sold somehow. Otherwise, at this rate I'm sure we'll continue to be regularly informed of the case for PYPL in 2027, 2028 and 2029.

GhostofBreadDragons

PFE is a good safe stock to hold. That dividend is very appealing and stable in a world that isn’t.  Then you just wait for their next big thing while collecting 6%

dvdmovie1

It's already broken out. XBI had a good year last year for once in a long while - in recent years, it's seemed as if the category broadly struggled while you could do well if you picked a narrow group of right names. I had four names bought out last year. Biotech is incredibly risky and it depends on what you're looking for. If you're looking for GLP-1, there's LLY in the lead, NVO and a lot of also-rans that might get bought in the manner that PFE overpaid for MTSR. People also don't talk about aesthetics - I've done well with diversified dermatology co GALDY in the last year.

EngineeringOptions

Why can't you? It would make more sense to get some experience using low priced tickers like F, PFE and so on. Big ETFs like QQQ and SPY will have you tying down at least 50k in a position

DisastrousPlantain51

So why would this stock in your opinion go to 100 from 6 dollars? Compared to NVO PFE MRK other related pharma stocks?

Punchmeinmyface25

Get PFE

dvdmovie1

Some of these are value traps imo, but I think there's also a patience issue when you go full port "cheap stocks" in a market like this rather than having it be a part of a portfolio. It's rare that I see people that have some exposure to value and some to growth - people seem to have to be in one tribe or the other and when they go fully into one tribe they often talk down the other. In 2023, people on here were incessantly pumping PYPL because it was "cheap" and NVDA had "gone up too much." We all know what NVDA did since, while PYPL has gone largely nowhere. All the discussions in 2023 how people should buy PFE instead of LLY because it was "cheap and had an obesity drug too." A couple of years later, PFE is below where it was and the obesity drug in question was a failure. People keep treating something like PYPL as if the fintech theme is what it was 4-5 years ago. People keep talking up PYPL down 76% in 5 years and the company formerly known as Square is down 70% in the same time frame. Not saying these aren't optically inexpensive but when both names have done absymally during a fantastic period for growth, I think what I don't agree with are these unbalanced takes that "everything is great with this company and nobody gets it." At some point this may attract a bit more attention if people turn towards value, but after three years of hearing about how cheap this is on here isn't there a point where people think maybe this is cheap for a reason? "Adobe, Forward PE of 13 and everyone uses it (also most likely to integrate AI, likely hug rally on that)" It is argubly cheap but that's not a thesis and you don't address the concerns that have gotten it to the point it is. How many other AI image generation tools are out there now? If ADBE sells seat based software to an ad agency and there's less need for as many people to do the same tasks because of AI, what happens to something like ADBE? Lately it's gone beyond ADBE and a lot of software names have struggled in recent months, too.

Negative_Win_5117

Even my Boomer shit is mostly green even before accounting for dividends - MO, LMT, CVX, UPS, INTC. A few losers in there like PFE and PYPL but I feel like I can’t hardly lose. Now I’m nervous.

No-Improvement3164

Why does PFE stock even exist?

BahnMe

Of course like an idiot I bought PFE instead a couple months ago since they were so “undervalued”. Maybe they’re “undervalued” because they’re incompetent.

Happy-Champion1661

PFE pumping

AlGAdams

Im in SPY, SCHD, AMZN, MU, KSPI, PFE at a yearly P/L of 34.5% with additional yield from CC sometimes. But yeah Im considering 100% in Beyond meat 

Punchmeinmyface25

PFE cure cancer and fat

ShareholderSLO85

I have hopes for PFE, MRK and BMY.

yellowstickypad

Whoever called out PFE calls for 1/16, bless you. (No chance I find the original comment in a WSB thread this week)

Thisispaartaaa

PFE calls it is!

Choice-Shame2035

I’d add PFE, I own it just because of their nice div, but def don’t like the company.

BigWarning8696

PFE has awful management

PaperHandsTheDip

leaps are boring tho, so maybe just full port weeklies and pray ¯\\\_(ツ)\_/¯ I've been in & out of PFE a few times. Seems relatively stable around here, not much downside imo. Might take a while to recover tho. Solid div if you're into the shares tho

RangerAdmirable9102

Eh. I was highly invested in all the big tech names before April. After the dip, my portfolio was down over 20%. I sold during the recovery, some at a loss, some at a gain. Most of those are much higher than they were. But I divested from Tech and started focusing on value and stocks with more growth runway. My portfolio is up 50% from April and 25% since October. I sold “winners,” and I think most people would regret selling like I did. I see it as freeing up capital for other price movements and I have a mix of solid companies with nice dividends (like PFE and KMB, to help me weather the bad days) and growth stocks like ASTS and RKLB. Im avoiding AI. Yes, I see the growth potential, but I also think there’s a lot of financial manipulation, pre revenue companies that are all hype, and companies that won’t be profitable for years trading at obscene multiples.

Historical-Radio-349

PFE you’ll be in time for the 1/23 ex div

corundum9

CVX, XOM, NKE, PFE, and DOW/LYB if you think chemical markets will cyclically improve

wylekebber

I would drop oil; it's organic and not as difficult to produce as lobbies would previously had us believe and nicotine is a nootropic. Food processing $PEP, $KHC, $TSN and pharma are much more mischievous imo; $JNJ, $LLY, $PFE. Or you could just have a portfolio of 100% T-bills and loan money to the US Government.

Unable_Illustrator_2

Pfizer (PFE)

Excellent-Mud2091

Dick pills was all you had to say. Calls on PFE

TheInkDon1

You're welcome. And well, you know how long Calls work I think, right? Because you're thinking of buying them on PFE. Do you know how CCs work? I mean, beyond, "I can sell these and get some cash"? Have you ever taken the time to figure out what the Return on Investment or Return on Capital is? (There's probably an esoteric difference between those 2 terms, but I just tend to use ROI: if *this* much is at risk, and I made *that* much, then how much did I earn as a *percentage*?) You're thinking of selling CCs against your Pfizer shares, so let's start there. Share price (spot) is 25.18. It's generally recommended to sell CCs at 30-delta or less, 30-45 days out (TastyTrade and others say that.) But 28 days isn't too much of a stretch so let's use that, 4 weeks. (And being it's the weekend now, it means I don't have to go out to 5 weeks, 35DTE, to stay inside 30-45 days.) Pfizer has $1-wide strikes, a bit unusual when sot is 25, so we get to choose 26-delta or....ITM. So we choose the 28DTE 26-delta 26C selling for 0.19. To calculate ROI, simply divide by the share cost, so: 0.19 / 25.18 = 0.75% in 4 weeks There are 13 4-week periods in a year, so x13 to get 9.8%. Decidedly underwhelming. But don't forget the 6.9% dividend yield, so add to get 16.7%. And now you've almost exactly matched what SPY did over the past year, 16.8% over the past year. And for very little work, just 5 minutes of selling a Call once a month. But then, why not just invest in SPY for zero extra work. But you're considering selling Pfizer, yes? So what if you sold the just-ITM 25C's for 0.59? That would be you saying, "I'd be fine with letting these shares go for $25, but in the month until then, I'll take the 41-cent extrinsic/theta value of those Calls and put it in my pocket. So then you get to divide that 0.41 'real' Premium (because 0.18 of the 0.59 cost was just the buyer paying for equity in PFE) by 25.00 (the strike price) to get: 0.41 / 25 = 1.64%. Apy to 21.3%, add the 6.9% dividend yield to get 28%. And that's quite spiffy! But how would you get that without having your shares called away? 1) By having PFE close below 25 in 4 weeks (just a 0.7% drop). Or, 2) Buying back that short Call when it's lost half its value. Because that's how we're "supposed" to do those. So you see, **if PFE will just stay flat**, you could do that about every 2 weeks, earn half that premium. And 26 times of getting half of something is the same as getting the whole something 13 times. Now, make sure I've got your full attention, because **this is where the magic happens.**

TheInkDon1

It's too funny you mentioned LEAPS Calls on Pfizer today! Here's why: I had an email from US News & World Report this morning about the 9 highest dividend-paying stocks in the S&P. (Why they didn't pick 10 I don't know; just to stand out a bit?) And since I hadn't checked on dividends lately, I had a look. They were about what I expected: 6.6% up to 12.6%. Though tbh, I wouldn't have guessed over 10%. I'm not a dividend investor. But I AM a PMCC trader, so I thought, "Let me see if any of these are stable enough that they don't lose value while I write 2-4 week Calls against them." Verizon was the first one to pass that screen, but Pfizer was next, down 5% over the past year, but mostly flat on the 6-month, 3m, and 1m views. To answer your specific question: I wouldn't be buying Pfizer LEAPS Calls for speculation. It's chart just doesn't support it, to my eye. **But as a stable base for selling Premium against?** Let's look at that. I buy LEAPS Calls (for speculation) just a year out, and not less than 80-delta. Here that would be the Jan'27 20 Calls at 86-delta for **5.40**. I sell Calls just 2 weeks out, and nominally at 30-delta. But if Pfizer isn't going to move, then why not right ATM? The 16Jan25.5C's at 38-delta are selling for **0.24**. ROI: 0.24 / 5.40 = 4.4% in 2 weeks. And that's pretty spiffy! Because that apy's to 115%. Okay, but what did I leave out of the "which LEAPS Call to buy" discussion? The time value I'd be paying for. It's 0.21, or $21 over the 378-day life of the Call. 5.5 cents per day. 1) That's very low, as these things go. Just 4% of the cost of the Call. Compare that (at the same Delta) to other tickers I trade: 12.5% for XBI, and 19% for SLV. 2) Just 1 sale of a 2-week Call more than pays for it. I can live with that. Because going out farther in time, and/or higher in Delta, to minimize theta-per-day, also makes the denominator of the ROI calc larger, reducing that theoretical 120% apy return. And remember too that PFE could go down, and we'll want that premium to buffer that. And because I put my money where my mouth is: [I took that position](https://imgur.com/a/IwxD3GX) Just an exploratory $500 position, but I may expand on that. And/or add similar trades from dividend-paying stocks I like. Sorry for all the words, but I had to go where that took me. Take care.

Crew4815162342

https://preview.redd.it/yha11hw7yzag1.png?width=1135&format=png&auto=webp&s=824e65e09fdba7137ab2c014cf8f364f508e5387 Seagen being the closest. $PFE has also requested meetings with Angelo's the CEO of $SLS

panda-money-um

Big pharma. PFE is a great one

RanDumbPlay

Why PFE?

its_fkn_hot_here

Seems like you need some drug companies on here. I nominate PFE.

Reasonable-Guest2392

Okay, the comments aren’t really helpful technically, but also helpful realistically. So as a new investor myself, 2 things I learn are 1)high reward comes with high risk, but high risk doesn’t necessarily contribute to high reward. 2)Everyone has a tolerance, and the right approach is unique. So set your own expectations. Personally for me 12-15% annual return! I tried to test different approaches (whatever comfortable). I tried to DCA FZROX and FZILX and small cap FZIPX for some months, and I didn’t know the small cap and sold for like 2% profit. I also tried to high dividends stocks due to recent price sink, like UPS, target, and high reputation PEPSI, also came across Verizon and PFE. So for those stocks, I buy gradually as well, I only add more if they sink, and when they rise like 5% in a week or so, I’ll sell, cuz annual returns already past my expectations 12-15%! I did hold a couple of times, for example Pepsi, reached 7% in 2 weeks but 2% still before I sold after 3 months! You do the maths. All above just make me stay in the track! The bonus is when I trade coreweave! When they tank like 20% in a week, I started to buy little by little, and when it pops up, I sell after couple of days, once made 12% and another time 22%! So the key for my “day trade” is NOT greedy! Buy dip sell high ONLY! Hope it helps. Good luck to all of us in 2026!

IntentionDeep651

PFE avoiding tariffs than hiking the price anyway , lmao they played everyone 

PatFlynnEire

Split it among CRMD, BFLY and PFE and write monthly calls on PFE.

AlGAdams

Bought and sold CVX AMZN DELL VISA META CRWV MU Holding into 2026 AMZN PFE KSPI MU UNH Trying to increase positions in PFE and UNH

RealityAddict333

PFE

IDrinkSulfuricAcid

Oh boy, there's much better dividend stocks! You could go with Verizon (VZ) which has a 6.82% dividend. Altria (MO) has a 7.36% dividend. 6.86% on Pfizer (PFE). Western Union (WU) offers a 10% dividend. Obviously the drawback is that a lot of these stocks don't grow or some are actively going down. Chevron has a relatively lower dividend compared to these, but it's stable. From these, I would choose VZ.

Lazy-Gene-7284

I agree on that part, just not sure you need “ bonds” or dividend bearing equivalents at your age. I retired a year ago and 20-25% on my holdings are now in dividend payers like VZ , PFE and others, with 10-15% in money markets and bonds. Yields are a lot better and they have some potential upside as rates turn lower

sudharsansai

Calls on PFE

obee1can

$PFE

LoveLaughterPizza

PFE

True_Veterinarian443

Unveiling PFE: https://www.reddit.com/r/StockMonitoring/s/7w8sCJLDhI

True_Veterinarian443

Unveiling PFE: https://www.reddit.com/r/StockMonitoring/s/7w8sCJLDhI

True_Veterinarian443

Unveiling PFE: https://www.reddit.com/r/StockMonitoring/s/7w8sCJLDhI

True_Veterinarian443

Unveiling PFE: https://www.reddit.com/r/StockMonitoring/s/7w8sCJLDhI

True_Veterinarian443

Unveiling PFE: https://www.reddit.com/r/StockMonitoring/s/7w8sCJLDhI

True_Veterinarian443

Unveiling PFE: https://www.reddit.com/r/StockMonitoring/s/7w8sCJLDhI

True_Veterinarian443

Unveiling PFE: https://www.reddit.com/r/StockMonitoring/s/7w8sCJLDhI

InternetIsntMyFrend4

Plus you need to pay taxes on your Capital gains.  You should look into dividend income from SCHD or companies like PFE.

BLVCKYOTA

Oh PFE is green, that’s why things are stalled.

KawaiiGeorgiaPeach

25yo student with no job. I have had a portfolio since 2023. I was given most of this by my father and don’t know where to start looking for advice. I bought VTI, VXUS, and BND after reading about 3 fund portfolios. What do I move around? Need to maximize growth so I can afford food while in school. Can’t afford much risk now. KO 2 shares SLV 1 share PFE 50 shares bought by grandfather in the 1960s SPYM 3 shares since I can’t buy fractional VOO VOO 38 shares BND 2 shares have not made money VXUS 2 shares VTI 3 shares

AluminiumCaffeine

I dont know pharma well for NVO/PFE, I dont understand how NVO is so cheap but the market seems to be set on smashing it down. NKE I dont follow closely but its tough in retail with rises and falls ala LULU. could work for sure though if it got its stride back